Deprescribing

From WikiMD's WELLNESSPEDIA

A variety of pills, which may be considered for deprescribing.

Deprescribing is the systematic process of identifying and discontinuing medications that are no longer necessary or that may be causing harm. This practice is particularly important in geriatric medicine and polypharmacy, where patients are often prescribed multiple medications.

Purpose[edit]

The primary goal of deprescribing is to reduce polypharmacy and minimize the risk of adverse drug reactions. It aims to improve patient outcomes by ensuring that medications are used appropriately and effectively. Deprescribing is a patient-centered approach that involves careful consideration of the risks and benefits of each medication.

Process[edit]

The process of deprescribing involves several steps:

  1. Medication Review: A comprehensive review of all medications a patient is taking, including prescription drugs, over-the-counter medications, and supplements.
  2. Risk-Benefit Analysis: Evaluating the potential benefits and harms of each medication in the context of the patient's overall health status and goals of care.
  3. Prioritization: Identifying which medications are most appropriate for discontinuation based on the risk-benefit analysis.
  4. Implementation: Gradually tapering or stopping medications, monitoring for withdrawal effects or symptom recurrence.
  5. Follow-up: Regularly reviewing the patient's condition and adjusting the medication regimen as necessary.

Challenges[edit]

Deprescribing can be challenging due to several factors:

  • Patient Resistance: Patients may be reluctant to stop medications they believe are beneficial.
  • Complexity of Care: Patients with multiple chronic conditions may have complex medication regimens.
  • Lack of Guidelines: There may be limited evidence or guidelines on how to safely discontinue certain medications.

Benefits[edit]

Deprescribing can lead to numerous benefits, including:

  • Reduced Medication Burden: Decreasing the number of medications can simplify treatment regimens and improve adherence.
  • Improved Quality of Life: Reducing unnecessary medications can decrease side effects and improve overall well-being.
  • Decreased Healthcare Costs: Fewer medications can lead to lower healthcare costs for both patients and healthcare systems.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.